Osmotica Pharm Us Company Profile
✉ Email this page to a colleague
What is the competitive landscape for OSMOTICA PHARM US, and what generic and branded alternatives to OSMOTICA PHARM US drugs are available?
OSMOTICA PHARM US has eight approved drugs.
Summary for Osmotica Pharm Us
| US Patents: | 0 |
| Tradenames: | 8 |
| Ingredients: | 7 |
| NDAs: | 8 |
Drugs and US Patents for Osmotica Pharm Us
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Osmotica Pharm Us | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205327-005 | Jul 28, 2017 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| Osmotica Pharm Us | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205327-004 | Jul 28, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Osmotica Pharm Us | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205327-001 | Jul 28, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Osmotica Pharm Us | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205327-003 | Jul 28, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Osmotica Pharm Us | HYDROMORPHONE HYDROCHLORIDE | hydromorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205629-001 | Jul 7, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Osmotica Pharm Us
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Osmotica Pharm Us | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022104-001 | May 20, 2008 | 6,403,120 | ⤷ Sign Up |
| Osmotica Pharm Us | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022104-002 | May 20, 2008 | 6,419,958 | ⤷ Sign Up |
| Osmotica Pharm Us | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022104-003 | May 20, 2008 | 6,403,120 | ⤷ Sign Up |
| Osmotica Pharm Us | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022104-004 | May 20, 2008 | 6,419,958 | ⤷ Sign Up |
| Osmotica Pharm Us | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022104-004 | May 20, 2008 | 6,403,120 | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
